关注
Ahmet Gül
标题
引用次数
引用次数
年份
Immunosuppressive therapy in lupus nephritis: the Euro‐Lupus Nephritis Trial, a randomized trial of low‐dose versus high‐dose intravenous cyclophosphamide
FA Houssiau, C Vasconcelos, D D'Cruz, GD Sebastiani, ER Garrido, ...
Arthritis & Rheumatism 46 (8), 2121-2131, 2002
13262002
Familial Mediterranean fever (FMF) in Turkey: results of a nationwide multicenter study
M Tunca, S Akar, F Onen, H Ozdogan, O Kasapcopur, F Yalcinkaya, ...
Medicine (Baltimore) 84 (1), 1-11, 2005
10262005
EULAR recommendations for the management of Behçet disease
G Hatemi, A Silman, D Bang, B Bodaghi, AM Chamberlain, A Gul, ...
Annals of the rheumatic diseases 67 (12), 1656-1662, 2008
10062008
2018 update of the EULAR recommendations for the management of Behçet’s syndrome
G Hatemi, R Christensen, D Bang, B Bodaghi, AF Celik, F Fortune, ...
Annals of the Rheumatic Diseases 77 (6), 808-818, 2018
7962018
Genome-wide association study identifies variants in the MHC class I, IL10, and IL23R-IL12RB2 regions associated with Behcet's disease
EF Remmers, F Cosan, Y Kirino, MJ Ombrello, N Abaci, C Satorius, JM Le, ...
Nature genetics 42 (8), 698-702, 2010
7612010
The 10-year follow-up data of the Euro-Lupus Nephritis Trial comparing low-dose and high-dose intravenous cyclophosphamide
FA Houssiau, C Vasconcelos, D D’Cruz, GD Sebastiani, ...
Annals of the rheumatic diseases 69 (01), 61-64, 2010
6082010
Genome-wide association analysis identifies new susceptibility loci for Behcet's disease and epistasis between HLA-B* 51 and ERAP1
Y Kirino, G Bertsias, Y Ishigatsubo, N Mizuki, I Tugal-Tutkun, E Seyahi, ...
Nature genetics 45 (2), 202-207, 2013
5992013
Prevalence of Behçet's disease in Istanbul, Turkey
G Azizlerli, A Akdağ Köse, R Sarıca, A Gül, İT Tutkun, M Kulaç, R Tunç, ...
International journal of dermatology 42 (10), 803-806, 2003
5752003
Loss-of-function mutations in TNFAIP3 leading to A20 haploinsufficiency cause an early-onset autoinflammatory disease
Q Zhou, H Wang, DM Schwartz, M Stoffels, YH Park, Y Zhang, D Yang, ...
Nature genetics 48 (1), 67-73, 2016
5642016
Early response to immunosuppressive therapy predicts good renal outcome in lupus nephritis: lessons from long‐term followup of patients in the Euro‐Lupus Nephritis Trial
FA Houssiau, C Vasconcelos, D D'Cruz, GD Sebastiani, ...
Arthritis & rheumatism 50 (12), 3934-3940, 2004
4732004
Canakinumab for the treatment of autoinflammatory recurrent fever syndromes
F De Benedetti, M Gattorno, J Anton, E Ben-Chetrit, J Frenkel, ...
New England Journal of Medicine 378 (20), 1908-1919, 2018
4522018
Anti-TNF therapy in the management of Behçet's disease—review and basis for recommendations
PP Sfikakis, N Markomichelakis, E Alpsoy, S Assaad-Khalil, B Bodaghi, ...
Rheumatology 46 (5), 736-741, 2007
4342007
Behcet's disease: an update on the pathogenesis
A Gul
Clinical and experimental rheumatology 19 (5; SUPP/24), S-6, 2001
4222001
Efficacy of infliximab in the treatment of uveitis that is resistant to treatment with the combination of azathioprine, cyclosporine, and corticosteroids in Behçet's disease …
I Tugal‐Tutkun, A Mudun, M Urgancioglu, S Kamali, E Kasapoglu, ...
Arthritis & Rheumatism: Official Journal of the American College of …, 2005
4062005
Classification criteria for autoinflammatory recurrent fevers
M Gattorno, M Hofer, S Federici, F Vanoni, F Bovis, I Aksentijevich, ...
Annals of the rheumatic diseases 78 (8), 1025-1032, 2019
3722019
Overproduction of monocyte derived tumor necrosis factor alpha, interleukin (IL) 6, IL-8 and increased neutrophil superoxide generation in Behçet's disease. A comparative study …
JL Mege, N Dilsen, V Sanguedolce, A Gul, P Bongrand, H Roux, L Ocal, ...
The Journal of rheumatology 20 (9), 1544-1549, 1993
3641993
Familial aggregation of Behcet's disease in Turkey
A Gül, M Inanç, L Öcal, O Aral, M Koniçe
Annals of the rheumatic diseases 59 (8), 622-625, 2000
3552000
Pulmonary manifestations of Behçet's disease
F Erkan, A Gül, E Tasali
Thorax 56 (7), 572-578, 2001
3462001
COVID‐19 is a Real Headache!
H Bolay, A Gül, B Baykan
Headache: The Journal of Head and Face Pain 60 (7), 1415-1421, 2020
3412020
Induced-pluripotent-stem-cell-derived primitive macrophages provide a platform for modeling tissue-resident macrophage differentiation and function
K Takata, T Kozaki, CZW Lee, MS Thion, M Otsuka, S Lim, KH Utami, ...
Immunity 47 (1), 183-198. e6, 2017
3242017
系统目前无法执行此操作,请稍后再试。
文章 1–20